99 related articles for article (PubMed ID: 15190636)
1. Interferon induced glomerular disease in a patient with chronic hepatitis C.
Suresh RL; Suryati Y; Merican I
Med J Malaysia; 2003 Oct; 58(4):594-6. PubMed ID: 15190636
[TBL] [Abstract][Full Text] [Related]
2. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
3. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection.
Sidhu-Malik NK; Kaplan AL
J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations].
Zarebska-Michaluk D; Lebensztejn DM; Kryczka W
Przegl Epidemiol; 2007; 61(3):551-8. PubMed ID: 18069393
[TBL] [Abstract][Full Text] [Related]
5. Liver function under interferon/ribavirin therapy of chronic hepatitis C.
Stintzing S; Schmitt C; Ocker M; Ganslmayer M; Zopf S; Gahr S; Hahn EG; Herold C
Hepatogastroenterology; 2009; 56(90):462-5. PubMed ID: 19579621
[TBL] [Abstract][Full Text] [Related]
6. [The adherence in the treatment of chronic hepatitis C].
Pawłowska M; Halota W
Pol Merkur Lekarski; 2005 Apr; 18(106):469-72. PubMed ID: 16161937
[TBL] [Abstract][Full Text] [Related]
7. Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy.
Berk DR; Mallory SB; Keeffe EB; Ahmed A
Clin Gastroenterol Hepatol; 2007 Feb; 5(2):142-51. PubMed ID: 16919505
[TBL] [Abstract][Full Text] [Related]
8. An adult case with onset of celiac disease during chronic hepatitis C antiviral treatment.
Ioniţă-Radu F; Bucurică S; Costache R; Nuţă P; Stanciu S
Rom J Intern Med; 2010; 48(1):105-8. PubMed ID: 21180248
[TBL] [Abstract][Full Text] [Related]
9. Outcome of combined interferon-ribavirin in the treatment of chronic hepatitis C.
Muhammad N; Jan MA; Rahman N
J Coll Physicians Surg Pak; 2004 Nov; 14(11):651-3. PubMed ID: 15530272
[TBL] [Abstract][Full Text] [Related]
10. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR
Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
[TBL] [Abstract][Full Text] [Related]
11. [Retreatment of patients with chronic hepatitis C].
Ostojić R
Acta Med Croatica; 2005; 59(5):447-51. PubMed ID: 16381242
[TBL] [Abstract][Full Text] [Related]
12. [The influence of HCV infection and immunomodulating therapy (interferon-alpha and ribavirin) on the condition of minor salivary glands and oral mucosa].
Sulka A; Simon K; Jeleń M; Piszko P
Przegl Epidemiol; 2005; 59(2):455-66. PubMed ID: 16190554
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease.
Abdelmalek MF; Liu C; Valentine JF
Am J Gastroenterol; 2007 Jun; 102(6):1333-4. PubMed ID: 17531027
[No Abstract] [Full Text] [Related]
14. IFN/RBV treatment induced neutropenia and its correction with neupogen in patients with hepatitis C.
Sharvadze L; Gochitashvili N; Tophuria A; Bolokadze N; Tsertsvadze T
Georgian Med News; 2007 Jun; (147):52-5. PubMed ID: 17660602
[TBL] [Abstract][Full Text] [Related]
15. Ribavirin in the treatment of hepatitis C.
Abonyi ME; Lakatos PL
Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
[TBL] [Abstract][Full Text] [Related]
16. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH
P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of adverse effects in ribavirin and interferon combination therapy].
Izumi N
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):523-7. PubMed ID: 15359855
[No Abstract] [Full Text] [Related]
18. [Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon].
Sarrecchia C; Niutta P; Testore GP; Sordillo P; Proietti F; Andreoni M
Recenti Prog Med; 2001 May; 92(5):336-9. PubMed ID: 11413892
[TBL] [Abstract][Full Text] [Related]
19. Acute onset of nephrotic syndrome during interferon-alpha retreatment for chronic active hepatitis C.
Nishimura S; Miura H; Yamada H; Shinoda T; Kitamura S; Miura Y
J Gastroenterol; 2002; 37(10):854-8. PubMed ID: 12424571
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of extrahepatic manifestations associated with hepatitis C virus infection].
Cacoub P
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B210-9. PubMed ID: 12180291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
